India Midcap Healthcare: Lupin continues the growth chip

With Sales growing in India, Japan and South Africa and progress on three dfifferent molecules Lupin ended June 30 with $1.5 bln run rate for the year scoring Rs1.5 bln in Sales.

Comments are closed.

Up ↑

%d bloggers like this: